With 6 years of dedicated work at Paras Biopharmaceuticals and the use of Paras Biopharmaceuticals’ unique technology platform (which comprises of.
Company has a strong track record of offering end-to-end Biologics CDMO Services, developing complex biologics, inc development & licensing of biosimilars.
Paras Biopharmaceuticals is pleased to announce that the company has been identified as one of the Fastest Growing Companies in the Nordic Biotechnology.